Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Lawsuit Filed Over Abilify Childhood Diabetes Risk August 29, 2014 Irvin Jackson Add Your Comments A product liability lawsuit has been filed by a 21 year old woman, alleging that she developed diabetes when she was 15 years old due to side effects of Abilify, a popular antipsychotic medication that has been linked to an increased risk of childhood diabetes. The complaint was filed by Cheyenne Beth Confer on August 22, in the Supreme Court of New York for New York City, naming Bristol-Myers Squibb and Otsuka American Pharmaceutical Inc. as defendants. According to allegations raised in the lawsuit, the drug makers failed to adequately warn about the childhood diabetes risk from Abilify, indicating that the average dose of the medication increases the risk of diabetes 7.72 percent above normal. Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION Confer was prescribed Abilify in 2009, when she was only 15 years old. Within six months, she had gained about 30 pounds and was diagnosed with Type II diabetes, which the complaint alleges were caused by side effects of the drug. Confer indicates that she had no prior history of diabetes or impaired glucose tolerance, and is now required to take Metformin for her diabetes and faces other health risks associated with the condition. “Despite being on the United States market for twelve years, the current labeling for Abilify entirely fails to provide accurate and meaningful information to physicians or anyone else about the potential relative risk to children taking Abilify for the development of Type II diabetes,” states Confer’s lawsuits. Abilify Diabetes Side Effects for Children Abilify (aripiprazole) was approved by the FDA in 2002, jointly developed and marketed by Bristol-Myers Squibb and Otsuka. It is part of a class of drugs known as atypical antipsychotics, which also include Risperdal, Seroquel, Zyprexa and others. Amid aggressive marketing that has promoted Abilify as safe and effective, the medication has grown to become one of the most widely used atypical antipsychotic medications in the United States. In 2009, Abilify sales were more than $3.3 billion, with a large increase in use of the medication seen among children, for “off-label” conditions, such as attention-deficit hyperactivity disorder (ADHD) or other disruptive behaviors. While all atypical antipsychotic medications have been associated with an increased risk of weight gain and diabetes, research has highlighted that children taking Abilify or other similar medications may be at a particularly high risk, facing a life-time of medical issues. “The data in children over the last several years demonstrate that children are more sensitive than adults to metabolic adverse effects of atypical antipsychotics,” according to the complaint filed by Confer. “Children tend to gain proportionately more weight and do so more rapidly during treatment than adults. Because drug-induced metabilic changes can persist over time and may not be fully reversible upon drug discontinuation, the implications for future health outcomes can be profound.” Overprescription of Atypical Antipsychotics Confer’s lawsuit also accuses Bristol-Myers Squibb and Otsuka of illegally promoting Abilify for uses not approved by the FDA. Bristol-Myers Squibb was forced to pay more than $515 million in 2007 to the U.S. Department of Justice (DOJ) to resolve similar charges that the company engaged in illegal marketing and pricing schemes, giving illegal kickbacks to doctors and other health care providers that pushed the drug to patients and for “off-label” promotions. While doctors can prescribe a drug for any reason they see fit, drug manufacturers are barred from promoting the drug for any use not specifically approved by the FDA. At the time of Confer’s use, the drug makers had not received approval to promote Abilify to children, but the federal government accused the company of doing so in defiance of U.S. law. In recent years, there has been increasing concerns about the use of Abilify and other atypical antipsychotic medications among children and teens, potentially exposing them to a number of serious side effects, including childhood diabetes, weight gain and other health problems. In August 2013, the Office of the Inspector General at the Department of Health and Human Services (DHHS) launched an investigation into the prescription of Abilify, Risperdal and similar antipsychotics to children. The investigation came as concerns increased over the rampant prescription of powerful psychotropic drugs to those under the age of 18, often for psychological disorders the drugs were not designed to treat. According to Confer’s complaint, there are currently more than 500,000 children nationwide being prescribed antipsychotics for a variety of disorders, including Attention Deficit Hyperactivity Disorder (ADHD), depression, anxiety, obsessive compulsive disorder, bipolar disorder, autism, schizophrenia, mania and psychosis. In some cases, children under the age of 1 years old have been given these drugs, the lawsuit claims. Confer accuses the drug makers of failure to warn, negligence, breach of warranty, and malicious, wanton, or reckless conduct. The complaint seeks compensatory and punitive damages for pain and suffering, mental anguish, physical disfigurement, physical impairment, past and future medical expenses, loss of wages and loss of earning capacity. Tags: Abilify, Antipsychotics, Bristol Myers Squibb, Childrens Drug, Diabetes, Risperdal More Abilify Lawsuit Stories Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019 Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019 Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018 1 Comments Terry July 13, 2016 My son is 15 and takes Abilify so many problems from him taking it to much to say on this please call it’s causing a lot of sexual behaviour and it’s uncontrollable to him and other health issues Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (Posted: today) Following 52 years as a cosmetologist, a New Jersey woman says she developed bladder cancer due to routine exposure to hair color chemicals. MORE ABOUT: HAIR DYE LAWSUITHair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)Hairdresser Bladder Cancer Lawsuits Target L’Oréal, Henkel, Wella, Clairol and Other Popular Salon Dye Manufacturers (04/04/2025)Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (03/28/2025) Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: yesterday) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025) 500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: yesterday) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)
Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019
Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019
Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018
Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (Posted: today) Following 52 years as a cosmetologist, a New Jersey woman says she developed bladder cancer due to routine exposure to hair color chemicals. MORE ABOUT: HAIR DYE LAWSUITHair Dye Cancer Lawsuit Filed Over Wrongful Death of Salon Professional (04/11/2025)Hairdresser Bladder Cancer Lawsuits Target L’Oréal, Henkel, Wella, Clairol and Other Popular Salon Dye Manufacturers (04/04/2025)Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (03/28/2025)
Galaxy Gas Lawsuit Filed Over Nitrous Oxide Addiction and Brain Injury Risks (Posted: yesterday) A class action lawsuit has been filed against Galaxy Gas and several associated companies, alleging the product is marketed to teens using sweet flavors and deceptive safety claims, leading to widespread addiction and neurological injuries. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Seeks Dismissal of Lawsuit Over Nitrous Oxide Death (04/21/2025)Nitrous Oxide Class Action Lawsuit Filed Over Fatal Side Effects of Flavored Gas Sold In Vape Shops (04/02/2025)
500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (Posted: yesterday) A federal judge has randomly selected a group of 500 Suboxone tooth decay lawsuits to go through case-specific discovery and further workup, which may eventually be eligible for early bellwether trials. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITStatus of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)